SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-067973
Filing Date
2020-06-01
Accepted
2020-06-01 06:54:30
Documents
3
Period of Report
2020-06-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2021449d1_8k.htm 8-K 22665
2 EXHIBIT 99.1 tm2021449d1_ex99-1.htm EX-99.1 74171
3 GRAPHIC tm2021449d1_ex99-1img001.jpg GRAPHIC 6697
  Complete submission text file 0001104659-20-067973.txt   107596
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 2161401
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 2161401 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33357 | Film No.: 20930874
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences